. Quality control of RISC-associated RNAs in muscle biopsies. A fraction (10%) of RISCassociated RNAs from a control biopsy was analyzed by qPCR for miR-1, miR-221 and U6 RNA enrichment (a) or for CDKN1B, FOS mRNAs and U6 RNA enrichment (b). RNU6-1 RNA is shown as negative control, since it is not associated to RISC. For both mRNA and microRNA analysis, differences in the amount of RNA immunoprecipitated by anti Ago2 antibodies (Ago2 IP) were calculated relative to RNA immunoprecipitated by control antibodies (ctr IP). A representative experiment is shown Figure S3 . Gene ontology analysis of the differentially modulated mRNAs in DM1 RISC. Circles represent specific gene ontology terms (GO Biological Process) or KEGG pathways that were significantly enriched in the list of mRNAs differently associated to the RISC in DM1 patients, as shown in Table S5 . Edges represent term connections within the ontology tree and colors highlight terms correlated in meaning. Term caption is coloured if the term is the most significant of the group. Gene names represent the characterizing, modulated genes that were used to start the enrichment.
Edges connect genes to all the terms that contain them. Genes in red are common to two or more correlated term groups. Primary fibroblasts were derived from skeletal muscle biopsies of DM1 patients and controls (CTR). Total RNA was extracted and the expression of miR-29c (a) and its target ASB2 (b) was analyzed by qPCR (DM1, n=4; CTR, n=3; *p<0.05).
